These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 36099411)

  • 21. The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug.
    Jalal B
    Psychopharmacology (Berl); 2018 Nov; 235(11):3083-3091. PubMed ID: 30288594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5-HT
    Schmitz GP; Jain MK; Slocum ST; Roth BL
    ACS Chem Neurosci; 2022 Aug; 13(16):2386-2398. PubMed ID: 35894503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the 5-HT
    Jaster AM; Elder H; Marsh SA; de la Fuente Revenga M; Negus SS; González-Maeso J
    Psychopharmacology (Berl); 2022 Jun; 239(6):1665-1677. PubMed ID: 35233648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LSD-stimulated behaviors in mice require β-arrestin 2 but not β-arrestin 1.
    Rodriguiz RM; Nadkarni V; Means CR; Pogorelov VM; Chiu YT; Roth BL; Wetsel WC
    Sci Rep; 2021 Sep; 11(1):17690. PubMed ID: 34480046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The 5-hydroxytryptamine 2A receptor agonists DOI and 25CN-NBOH decrease marble burying and reverse 8-OH-DPAT-induced deficit in spontaneous alternation.
    Odland AU; Jessen L; Kristensen JL; Fitzpatrick CM; Andreasen JT
    Neuropharmacology; 2021 Feb; 183():107838. PubMed ID: 31693871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Agonist-directed signaling of the serotonin 2A receptor depends on beta-arrestin-2 interactions in vivo.
    Schmid CL; Raehal KM; Bohn LM
    Proc Natl Acad Sci U S A; 2008 Jan; 105(3):1079-84. PubMed ID: 18195357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The serotonin 2A receptor agonist 25CN-NBOH increases murine heart rate and neck-arterial blood flow in a temperature-dependent manner.
    Buchborn T; Lyons T; Song C; Feilding A; Knöpfel T
    J Psychopharmacol; 2020 Jul; 34(7):786-794. PubMed ID: 32048564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the 5-HT
    Preller KH; Schilbach L; Pokorny T; Flemming J; Seifritz E; Vollenweider FX
    J Neurosci; 2018 Apr; 38(14):3603-3611. PubMed ID: 29555857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clozapine acts as an agonist at serotonin 2A receptors to counter MK-801-induced behaviors through a βarrestin2-independent activation of Akt.
    Schmid CL; Streicher JM; Meltzer HY; Bohn LM
    Neuropsychopharmacology; 2014 Jul; 39(8):1902-13. PubMed ID: 24531562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile.
    Holze F; Singh N; Liechti ME; D'Souza DC
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2024 May; 9(5):472-489. PubMed ID: 38301886
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro assays for the functional characterization of (psychedelic) substances at the serotonin receptor 5-HT
    Pottie E; Stove CP
    J Neurochem; 2022 Jul; 162(1):39-59. PubMed ID: 34978711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute serotonin 2A receptor activation impairs behavioral flexibility in mice.
    Amodeo DA; Hassan O; Klein L; Halberstadt AL; Powell SB
    Behav Brain Res; 2020 Oct; 395():112861. PubMed ID: 32814148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spectral signatures of serotonergic psychedelics and glutamatergic dissociatives.
    Pallavicini C; Vilas MG; Villarreal M; Zamberlan F; Muthukumaraswamy S; Nutt D; Carhart-Harris R; Tagliazucchi E
    Neuroimage; 2019 Oct; 200():281-291. PubMed ID: 31247301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Chronic Treatment With 5-HT
    Tsybko AS; Ilchibaeva TV; Filimonova EA; Eremin DV; Popova NK; Naumenko VS
    Neurochem Res; 2020 Dec; 45(12):3059-3075. PubMed ID: 33095437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological characterization of the LSD analog N-ethyl-N-cyclopropyl lysergamide (ECPLA).
    Halberstadt AL; Klein LM; Chatha M; Valenzuela LB; Stratford A; Wallach J; Nichols DE; Brandt SD
    Psychopharmacology (Berl); 2019 Feb; 236(2):799-808. PubMed ID: 30298278
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors.
    Vargas MV; Dunlap LE; Dong C; Carter SJ; Tombari RJ; Jami SA; Cameron LP; Patel SD; Hennessey JJ; Saeger HN; McCorvy JD; Gray JA; Tian L; Olson DE
    Science; 2023 Feb; 379(6633):700-706. PubMed ID: 36795823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tolerance and Tachyphylaxis to Head Twitches Induced by the 5-HT2A Agonist 25CN-NBOH in Mice.
    Buchborn T; Lyons T; Knöpfel T
    Front Pharmacol; 2018; 9():17. PubMed ID: 29467649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Animal models of serotonergic psychedelics.
    Hanks JB; González-Maeso J
    ACS Chem Neurosci; 2013 Jan; 4(1):33-42. PubMed ID: 23336043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pimavanserin exhibits serotonin 5-HT
    Muneta-Arrate I; Diez-Alarcia R; Horrillo I; Meana JJ
    Eur Neuropsychopharmacol; 2020 Jul; 36():83-89. PubMed ID: 32517960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A quantitative method for the selective 5-HT2A agonist 25CN-NBOH in rat plasma and brain.
    Breusova K; Ernstsen KG; Palner M; Linnet K; Kristensen JL; Kretschmann AC
    J Pharm Biomed Anal; 2021 May; 199():114016. PubMed ID: 33784574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.